These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 355080)

  • 1. Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function.
    Herbertson BM; Evans DB; Calne RY; Banerjee AK
    Histopathology; 1977 May; 1(3):161-78. PubMed ID: 355080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
    Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
    Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
    Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the kidney biopsy to predict allograft loss in a pediatric transplant population.
    Fennell RS; Donnelly WH; Purcell CA; Garin EH; Iravani A; Pfaff WW; Howard RJ; Richard GA
    Int J Pediatr Nephrol; 1986; 7(1):21-6. PubMed ID: 3514500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.
    Nadasdy T; Allen C; Zand MS
    Hum Pathol; 2002 Apr; 33(4):437-41. PubMed ID: 12055680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies.
    Wilczek HE
    Transplantation; 1990 Nov; 50(5):790-7. PubMed ID: 2238054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function.
    Lehtonen SR; Taskinen EI; Isoniemi HM
    APMIS; 1999 Oct; 107(10):945-50. PubMed ID: 10549592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection?
    Dimény E; Wahlberg J; Larsson E; Fellström B
    Clin Transplant; 1995 Apr; 9(2):79-84. PubMed ID: 7599406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of percutaneous biopsies from human renal allografts with early impaired function.
    Kiaer H; Hansen HE; Olsen S
    Clin Nephrol; 1980 Feb; 13(2):58-63. PubMed ID: 6988122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis.
    Olsen S; Burdick JF; Keown PA; Wallace AC; Racusen LC; Solez K
    Medicine (Baltimore); 1989 May; 68(3):173-87. PubMed ID: 2654537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy.
    Mengel M; Bock O; Priess M; Haller H; Kreipe H; Gwinner W
    Clin Nephrol; 2008 Jun; 69(6):408-16. PubMed ID: 18538116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function.
    Sofue T; Inui M; Kiyomoto H; Moritoki M; Nishioka S; Nishijima Y; Moriwaki K; Hara T; Kushida Y; Haba R; Yoda T; Hirao T; Kakehi Y; Nishiyama A; Kohno M
    Am J Nephrol; 2012; 36(2):127-35. PubMed ID: 22797609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature.
    Pham PT; Pham PC; Danovitch GM; Gritsch HA; Singer J; Wallace WD; Hayashi R; Wilkinson AH
    Am J Transplant; 2005 Oct; 5(10):2565-9. PubMed ID: 16162209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients.
    Solez K; Racusen LC; Marcussen N; Slatnik I; Keown P; Burdick JF; Olsen S
    Kidney Int; 1993 May; 43(5):1058-67. PubMed ID: 8510383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.